The absence of anti-Covid vaccine AstraZeneca from a delivery plan shared last week by the army has raised questions about the fate of the vaccine. The British manufacturer accounts for a seventh of the country’s vaccine dose orders.
On Sunday, the paper NZZ am Sonntag wrote that the federal government is considering selling or giving away the Swiss quota if market approval continues to be delayed or is eventually denied. The review is dragging on since October because the competent authority, Swissmedic, has requested additional clinical data from a study in the US.
Nora Kronig, who is in charge of vaccine procurement, told the NZZ am Sonntag that the data situation is currently uncertain, which is why AstraZeneca is not listed in the delivery plan. She added that withdrawal from the sales contract is not an option at the moment but said the order would be reexamined if the vaccine fails to get approval.
According to Kronig, Switzerland is not dependent on AstraZeneca doses and the government does not rule out passing on the doses to others if necessary. A spokesperson for AstraZeneca told the paper that the company is ready to swiftly deliver doses to Switzerland as soon as Swissmedic approves the vaccine.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Swiss watch industry calls for ‘clear solution’ with US
This content was published on
Federation of the Watch Industry calls for clear solution to tariff threat and a swift agreement between Bern and Washington.
Swiss youngsters illegally obtain alcohol in a quarter of test purchases
This content was published on
In a quarter of all alcohol test purchases last year, young people in Switzerland were able to obtain beer, wine or spirits illegally.
Swiss storm damage more frequent and more expensive
This content was published on
Storm damage has increased by 126% in the last ten years. Costs have risen by 133% in the same period, according to Helvetia Insurance.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss sign next vaccine agreement with AstraZeneca
This content was published on
Switzerland signs agreement with British pharma company AstraZeneca to pre-order up to 5.3 million doses of a Covid-19 vaccine under development.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.